Predicted protein targets (top 19)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KDM4E | B2RXH2 | 6/20 | 0.45 |
| ▸ | LMNA | P02545 | 4/20 | 0.45 |
| ▸ | HTT | P42858 | 4/20 | 0.44 |
| ▸ | MAPK1 | P28482 | 2/20 | 0.44 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.40 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.40 |
| ▸ | TP53 | P04637 | 1/20 | 0.40 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.40 |
| ▸ | HPGD | P15428 | 1/20 | 0.40 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.40 |
| ▸ | AR | P10275 | 1/20 | 0.39 |
| ▸ | MEN1 | O00255 | 2/20 | 0.39 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.39 |
| ▸ | HTR2A | P28223 | 1/20 | 0.39 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.37 |
| ▸ | GAA | P10253 | 3/20 | 0.37 |
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.37 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.36 |
| ▸ | MAPT | P10636 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL9980397 | 1.00 | KDM4E (0.45) | KDM4ELMNAHTTMAPK1TDP1 | |
| SCHEMBL9988607 | 1.00 | KDM4E (0.45) | KDM4ELMNAHTTMAPK1TDP1 | |
| SCHEMBL30931253 | 0.95 | LMNA (0.49) | KDM4ELMNAHTTMAPK1TDP1 | |
| SCHEMBL16008670 | 0.95 | LMNA (0.49) | KDM4ELMNAHTTMAPK1TDP1 | |
| SCHEMBL16009146 | 0.95 | LMNA (0.49) | KDM4ELMNAHTTMAPK1TDP1 | |
| SCHEMBL16008572 | 0.95 | LMNA (0.49) | KDM4ELMNAHTTMAPK1TDP1 | |
| SCHEMBL16008187 | 0.95 | LMNA (0.49) | KDM4ELMNAHTTMAPK1TDP1 | |
| SCHEMBL9978253 | 0.94 | LMNA (0.47) | KDM4ELMNAHTTMAPK1TP53 | |
| SCHEMBL16008090 | 0.89 | LMNA (0.53) | KDM4ELMNAHTTMAPK1NPSR1 | |
| SCHEMBL29825060 | 0.89 | LMNA (0.53) | KDM4ELMNAHTTMAPK1NPSR1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2539956-B1 | POLYETHER-FUNCTIONALIZED REDOX SHUTTLE ADDITIVES FOR LITHIUM ION BATTERIES | UCHICAGO ARGONNE LLC (US) | 2017-09-06 | — | — | EP | claimed |
| US-8609287-B2 | Polyether-functionalized redox shuttle additives for lithium ion batteries | UCHICAGO ARGONNE, LLC (US) | 2013-12-17 | — | — | US | claimed |
| US-20110294003-A1 | POLYETHER-FUNCTIONALIZED REDOX SHUTTLE ADDITIVES FOR LITHIUM ION BATTERIES | ENERGY, UNITED STATES DEPARTMENT OF | 2011-12-01 | — | — | US | claimed |
| EP-2539956-B1 | POLYETHER-FUNCTIONALIZED REDOX SHUTTLE ADDITIVES FOR LITHIUM ION BATTERIES | UCHICAGO ARGONNE LLC (US) | 2017-09-06 | — | — | EP | disclosed |
| US-8609287-B2 | Polyether-functionalized redox shuttle additives for lithium ion batteries | UCHICAGO ARGONNE, LLC (US) | 2013-12-17 | — | — | US | disclosed |
| US-20110294003-A1 | POLYETHER-FUNCTIONALIZED REDOX SHUTTLE ADDITIVES FOR LITHIUM ION BATTERIES | ENERGY, UNITED STATES DEPARTMENT OF | 2011-12-01 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110294003-A1 | POLYETHER-FUNCTIONALIZED REDOX SHUTTLE ADDITIVES FOR LITHIUM ION BATTERIES | NOX4, NDUFS3, NDUFS7 | KDM4E 3753/4885LMNA 2963/4885HTT 3292/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.